17 March 2016
Sky Media to use Yospace’s live ad insertion solution for Sky Go
Sky Media has chosen Yospace to provide a dynamic advertisement replacement solution for Sky Go, the leading ‘TV everywhere’ service in Europe. In addition to enabling dynamic ad serving on Sky Go Linear for the first time, Sky is now also able to reproduce the key...
15 March 2016
Abzena issues business update – strong second half momentum
Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, provides the following update. Broadening of service offering … As part of...
7 March 2016
GM&C Life Sciences Fund announces first investments
The GM&C Life Sciences Fund has announced that it has concluded its first two investments in February. The Fund, which is managed by Catapult Ventures and targets exciting life science investments in the Greater Manchester and Cheshire regions, has invested in...
1 March 2016
Michelson Diagnostics’ Dynamic OCT Imaging Technology reveals changes in Skin Blood Vessels in Real-Time
Maidstone, UK, 26 February 2016 – Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces data showing that its Dynamic OCT imaging technology is able to visualise in...
27 January 2016
Abzena announces significant licence deal for ThioBridge
Significant licence deal for ThioBridge™ ADC linker technology signed with US biotech partner … Cambridge, UK, 25 January 2016 – Abzena plc (AIM:ABZA), a life sciences group providing services and technologies to enable development and manufacture of...
25 January 2016
Catapult secures 9x cash return with sale of Accutronics
20 January 2016
Catapult Ventures appoints Dr Gareth King as Investment Manager
Catapult Ventures has announced the appointment of Dr Gareth King to its new GM&C Life Sciences Fund where he will be Investment Manager. Dr King joins Catapult from Critical Pharmaceuticals, a Catapult life sciences portfolio company, where he has been CEO for the last four...
19 January 2016
Abzena announces Antitope Consortium receives €1.9m European grant
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders … Cambridge, UK – 18 January 2016 – Abzena plc (AIM:ABZA), a life sciences group providing services and technologies to...
15 January 2016
Philips and Monica Healthcare announce collaboration for innovative fetal monitoring solution
New exclusive co-development agreement to develop new advancements in mother and child care … WHAT: Royal Philips today announced an exclusive global co-development agreement with Monica Healthcare, a leading supplier of abdominal fetal monitoring measurements. The two companies...